// App-Quantinova.ai

3325 : Combination of DNMT and HDAC inhibitors reprogram cancer stem cell signaling to overcome drug resistance

Researchers

Presenter

  • Rajneesh Pathania

Principal Investigators

  • Ravindra B. Kolhe

  • Sabarish Ramachandran

  • Gurusamy Mariappan

  • Priyanka Thakur

  • Puttur D. Prasad

  • Vadivel Ganapathy

  • Muthusamy Thangaraju

Medical Centers

  • Georgia Regents University, August, GA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Solid malignancies

Biomarkers

  • DNA methyltransferase 1

Drug/Treatment

  • 5-Azacytidine

  • Tamoxifen

  • Paclitaxel

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved